The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA

doi:10.2147/IDR.S159455

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/32179

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32179

標題:	The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
作者:	Lai, Chih-Cheng Chen, Chi-Chung Lu, Ying-Chen Chuang, Yin-Ching Tang, Hung-Jen
關鍵字:	MRSA silent mutation rpoB474 ciprofloxacin resistance
日期:	2018
上傳時間:	2019-11-15 15:43:57 (UTC+8)
出版者:	DOVE MEDICAL PRESS LTD
摘要:	Background: The aim of this study was to investigate the genotypic differences between different sequence type MRSA isolates, especially focusing on silent rpoB474 mutations and the relationship between such mutations and ciprofloxacin resistance. Methods: Seventy-nine MRSA isolates were obtained for antibiotic susceptibility tests and molecular study. Results: Among these isolates, we found that the MIC 50, MIC 90, and minimum inhibitory concentration (MIC) range of ciprofloxacin were much higher for the isolates without the rpoB474 mutation than for isolates with the rpoB474 mutation. A total of 87.5% of the isolates with the rpoB474 mutation were susceptible to ciprofloxacin, but none of the isolates without the rpoB474 mutation were susceptible to ciprofloxacin. For 27 MRSA isolates without rpo474 silent mutation but with gyrA86/126 silent mutation, all of them belonged to SCCmec III, and had high ciprofloxacin MIC levels. For another 44 MRSA isolates with rpo474 silent mutation but without gyrA86/126 silent mutation, all of them showed low ciprofloxacin MIC levels, all of them belonged to either SCCmec IV or V. Furthermore, MRSA ciprofloxacin resistance was found to be associated with the mutations gyrA S84L/parC S80F or gyrA S84L, and S85P/parC S80Y. Conclusion: Most occurrences of this rpoB474 silent mutation were found in community acquired-MRSA (CA-MRSA) isolates with susceptibility to most antibiotics, especially for ciprofloxacin and vice versa. Thus, this mutation may help to differentiate the different microbiologic characteristics of MRSA clinical isolates.
link:	http://dx.doi.org/10.2147/IDR.S159455
關聯:	Diabetes Metabolic Syndrome and Obesity-Targets and Therapy, v.11, pp.681-687
顯示於類別:	[保健營養系(所) ] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
10.2147-IDR.S159455.pdf		1031Kb	Adobe PDF	330	檢視/開啟
index.html		0Kb	HTML	1039	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....